What is Omeprazole?
Omeprazole is a proton pump inhibitor (PPI) — a widely prescribed class of medicines that reduces the production of stomach acid. It is approved by the European Medicines Agency (EMA) for the treatment of acid-related conditions including gastro-oesophageal reflux disease (GERD), peptic ulcers, and Helicobacter pylori eradication. Low-dose formulations are available without a prescription in many EU countries for short-term use.
How does Omeprazole work?
Omeprazole is a prodrug that is activated in the acidic environment of the stomach’s parietal cells. Once activated, it covalently binds to and irreversibly inhibits the H⁺/K⁺-ATPase enzyme (the proton pump) — the final common pathway for acid secretion into the stomach lumen:
- Acid secretion blockade: By inhibiting the proton pump, Omeprazole reduces gastric acid secretion regardless of the stimulus (food, histamine, gastrin, or acetylcholine). This is more complete acid suppression than H2-receptor antagonists (e.g., ranitidine, famotidine).
- Healing of mucosal damage: Reduced gastric acidity allows the oesophageal and gastric mucosa to heal, which is particularly important in reflux oesophagitis and peptic ulceration.
- H. pylori eradication support: Omeprazole raises intragastric pH to a level at which antibiotic activity against H. pylori is enhanced, making PPI-based triple therapy effective.
- Accumulation over days: Because Omeprazole inhibits only active pumps, and new pumps are continuously synthesised, maximum acid suppression builds up over the first 3–5 days of daily dosing rather than occurring after the first dose.
Who is Omeprazole for?
Omeprazole is indicated for:
- Gastro-oesophageal reflux disease (GERD): Including reflux oesophagitis, symptomatic GERD without oesophagitis, and maintenance to prevent relapse.
- Peptic ulcer disease: Treatment of gastric ulcers and duodenal ulcers, including prevention of NSAID-associated ulcers in high-risk patients.
- Helicobacter pylori eradication: In combination with two antibiotics (typically clarithromycin and amoxicillin or metronidazole) to cure H. pylori infection and reduce ulcer recurrence.
- Zollinger-Ellison syndrome: A rare condition of pathological gastric acid hypersecretion requiring high-dose PPI therapy.
- Self-treatment of heartburn: Low-dose (10–20 mg) OTC use in adults for occasional heartburn, for up to 14 days in many EU countries.
Omeprazole is not appropriate as a substitute for investigation when:
- Symptoms could indicate serious upper GI pathology (dysphagia, unexplained weight loss, persistent vomiting, bleeding)
- Alarm symptoms are present — these warrant urgent gastroenterological assessment
Posología
Dosage varies by indication and patient factors. Standard EMA-approved dosing for adults:
| Indicación | Dosis | Duración |
|---|---|---|
| Symptomatic GERD (no oesophagitis) | 20 mg once daily | 4 weeks |
| Reflux oesophagitis | 20–40 mg once daily | 4–8 weeks |
| GERD maintenance | 10–20 mg once daily | Ongoing (with review) |
| Duodenal ulcer | 20 mg once daily | 4 weeks |
| Gastric ulcer | 20–40 mg once daily | 4–8 weeks |
| H. pylori eradication (triple therapy) | 20 mg twice daily | 7 days (with antibiotics) |
| NSAID-associated ulcer prevention | 20 mg once daily | Duration of NSAID use |
| Short-term heartburn (OTC) | 10–20 mg once daily | Up to 14 days |
Omeprazole should be taken before eating, ideally 30–60 minutes before breakfast. Capsules should be swallowed whole; if swallowing is difficult, they can be opened and the pellets mixed with a small amount of acidic liquid (e.g., fruit juice) but should not be chewed.
Efectos secundarios
Omeprazole is generally well tolerated. Most side effects are mild and uncommon.
Efectos secundarios frecuentes (pueden afectar hasta a 1 de cada 10 personas)
- Headache
- Abdominal pain
- Diarrhoea
- Nausea
- Flatulence
- Constipation
Less common but important side effects
- Hypomagnesaemia: Low serum magnesium, particularly with long-term use (more than 3 months). Can cause muscle cramps, fatigue, tetany, and cardiac arrhythmias. Magnesium levels should be checked in patients on long-term PPI therapy.
- Vitamin B12 deficiency: Reduced gastric acid impairs B12 absorption from food. Risk increases with long-term use.
- Clostridium difficile (C. diff) colitis: Gastric acid provides a barrier to intestinal infection; PPI use is associated with a modestly increased risk of C. difficile colitis, particularly in hospital settings.
- Bone fractures: Long-term high-dose use has been associated with a modestly increased risk of osteoporotic fractures, possibly due to reduced calcium absorption.
- Interstitial nephritis: Rare but serious kidney inflammation associated with PPI use; often presents with non-specific symptoms.
- Subacute cutaneous lupus erythematosus (SCLE): Rare skin reaction associated with proton pump inhibitors; resolves on discontinuation.
Omeprazole vs alternatives
| Medicine | Class | Onset | Acid Suppression | Key Feature |
|---|---|---|---|---|
| Omeprazole | PPI | 3–5 days for max effect | Highest (irreversible pump inhibition) | Generic; widely available OTC at low doses |
| Lansoprazole | PPI | 3–5 days for max effect | High | Generally similar efficacy; some prefer tolerability profile |
| Pantoprazole | PPI | 3–5 days for max effect | High | Fewer drug interactions (less CYP2C19 dependence) |
| Esomeprazole | PPI | 3–5 days for max effect | Slightly higher in some studies | S-isomer of omeprazole; often similar clinical outcomes |
| Famotidine | H2 receptor antagonist | 1–3 hours | Moderate | Faster but less complete acid suppression; useful for on-demand relief |
Diferencias clave:
- Omeprazole vs Lansoprazole: Both are PPIs with similar clinical efficacy. Lansoprazole may be preferred by patients who experience side effects with omeprazole. Generic availability makes both cost-effective.
- Omeprazole vs H2 antagonists: H2 antagonists (famotidine) act faster but achieve less complete acid suppression. Tolerance (tachyphylaxis) develops to H2 antagonists over time; it does not occur with PPIs. PPIs are preferred for healing oesophagitis and H. pylori eradication; H2 antagonists may be useful for on-demand heartburn relief.
How to get Omeprazole online in Europe
Low-dose Omeprazole (10–20 mg) is available over the counter for short-term heartburn treatment in many EU member states. Higher doses and longer treatment courses require a prescription from a qualified medical professional.
Prescrivia opera como intermediario tecnológico: no prescribimos medicamentos, no empleamos médicos ni vendemos medicamentos. Nuestra plataforma conecta a los pacientes con médicos independientes registrados en la UE que pueden realizar evaluaciones de salud en línea confidenciales.
El proceso funciona de la siguiente manera:
- Complete una evaluación de salud: Answer structured health questions about your digestive symptoms, medical history, and current medications. This assessment is reviewed by an independent doctor.
- Revisión médica: Un médico independiente registrado en la UE revisa su evaluación. If prescription Omeprazole is clinically appropriate, they may issue a prescription. If not, the doctor will explain why.
- Prescripción y dispensación: Si se emite una receta, se envía a una farmacia asociada autorizada de la UE, que dispensa y envía el medicamento directamente a usted.
Importante: Prescrivia no garantiza que se emita una receta. Todas las decisiones de prescripción son tomadas de forma independiente por profesionales médicos cualificados en función de sus circunstancias clínicas individuales.
Información importante de seguridad
Seek urgent medical attention if you experience:
- Difficulty swallowing or pain when swallowing
- Unintentional weight loss
- Vomiting blood or material that looks like coffee grounds
- Black, tarry stools
- Persistent severe abdominal pain
These may be signs of serious upper gastrointestinal disease that requires investigation beyond PPI treatment.
Informe a su médico antes de starting Omeprazole if you have:
- Liver disease (Omeprazole is extensively metabolised by the liver)
- Kidney disease
- Osteoporosis or at risk of bone fractures
- A history of hypomagnesaemia
- Lupus
Interacciones medicamentosas: Omeprazole is metabolised by CYP2C19. It may reduce the antiplatelet effect of clopidogrel (an important interaction for patients with cardiovascular disease). It may also increase plasma levels of medicines metabolised by CYP2C19 (e.g., diazepam, phenytoin). Omeprazole may reduce the absorption of medicines requiring an acidic environment (e.g., itraconazole, atazanavir, erlotinib). Disclose all current medicines to your doctor.
Fuentes
La información médica de esta página se basa en las siguientes fuentes:
- European Medicines Agency (EMA). Losec (omeprazole) — Summary of Product Characteristics. Disponible en: ema.europa.eu
- World Health Organization (WHO). WHO Model List of Essential Medicines — Gastrointestinal section. who.int
- Malfertheiner P, et al. Management of Helicobacter pylori infection — the Maastricht V/Florence Consensus Report. Gut. 2017;66(1):6–30.
- Vaezi MF, et al. Complications of proton pump inhibitor therapy. Gastroenterology. 2017;153(1):35–48.
Este contenido se revisa periódicamente para reflejar las directrices clínicas actualizadas. Se proporciona únicamente con fines informativos y no constituye asesoramiento médico. Consulte siempre a un profesional sanitario cualificado para obtener asesoramiento relevante para sus circunstancias de salud individuales.
Frequently asked questions
- What is Omeprazole used for?
- Omeprazole is a proton pump inhibitor (PPI) approved by the EMA for the treatment of gastro-oesophageal reflux disease (GERD), peptic ulcers (gastric and duodenal), eradication of Helicobacter pylori infection (in combination with antibiotics), and conditions of excessive stomach acid production such as Zollinger-Ellison syndrome.
- How quickly does Omeprazole work?
- Omeprazole begins to inhibit acid production within 1–2 hours of the first dose, but maximum acid suppression develops over 3–5 days of regular daily use as the medicine accumulates in the stomach's proton pumps. For reflux symptom relief, most patients notice improvement within 2–4 days.
- Can I get Omeprazole online in Europe?
- Low-dose Omeprazole (10 mg or 20 mg) is available over the counter in many EU member states for short-term self-treatment of heartburn. Higher doses and longer treatment courses are available via prescription from an EU-registered doctor, which Prescrivia can facilitate through its platform.
- How long should I take Omeprazole?
- Duration depends on the indication. Reflux oesophagitis is typically treated for 4–8 weeks. Maintenance therapy for GERD may continue for months under medical supervision. PPIs should not be used long-term without regular medical review due to potential risks with prolonged use.
- Is Omeprazole safe for long-term use?
- Omeprazole is generally well tolerated. However, long-term use (more than 1 year) has been associated with an increased risk of certain conditions including hypomagnesaemia (low magnesium), vitamin B12 deficiency, and potentially an increased risk of bone fractures. Regular medical review is important for patients using PPIs long-term.
- Do I need a prescription for Omeprazole?
- Omeprazole 10–20 mg is available without a prescription for short-term use in many EU countries. Higher doses (40 mg) and prolonged treatment are typically prescription-only. A doctor should be consulted if symptoms persist beyond 2 weeks of self-treatment.
Prescrivia es únicamente una plataforma intermediaria. No prestamos servicios médicos, no prescribimos tratamientos ni dispensamos medicamentos. Todas las decisiones médicas son tomadas por médicos independientes registrados en la UE. Todos los medicamentos son dispensados por farmacias autorizadas de la UE. Esta plataforma facilita la conexión entre pacientes y profesionales sanitarios.